• OPEN AN ACCOUNT
Indian Indices
Nifty
25,839.65 -120.90
(-0.47%)
Sensex
84,398.16 -268.12
( -0.32%)
Bank Nifty
59,222.35 -16.20
( -0.03%)
Nifty IT
38,130.60 -460.10
( -1.19%)
Global Indices
Nasdaq
47,580.49 -179.84
(-0.38%)
Dow Jones
6,861.32 -6.19
(-0.09%)
Hang Seng
50,565.27 -89.83
(-0.18%)
Nikkei 225
9,640.52 -4.57
(-0.05%)
Forex
USD-INR
90.09 0.19
(0.21%)
EUR-INR
104.90 0.24
(0.23%)
GBP-INR
120.04 0.25
(0.21%)
JPY-INR
0.58 0.00
(0.12%)

EQUITY - MARKET SCREENER

Nalwa Sons Investments Ltd
Industry :  Finance & Investments
BSE Code
ISIN Demat
Book Value()
532256
INE023A01030
30828.5478599
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
NSIL
161.05
3345.93
EPS(TTM)
Face Value()
Div & Yield %
40.42
10
0
 

As on: Dec 10, 2025 02:56 PM



Particulars
Company Name Sanofi India Ltd
Face Value 10
BSE Code 500674
Year End 202412
Full Year
Equity ( in Cr.) 23.03
B.V. 339.60
Sales in Cr. 2,013.20
NP in Cr. 442.27
NP Var% -25.00
Div% 1,170.00
CPS 208.00
EPS 192.00
Traded Value( in Lakhs) 84.23
52 Week High 6,718.00
52 Week Low 4,146.00
Price BSE 4,344.00
Price NSE 4,345.00
Market Capital( in Cr.) 10,004.69
P/C Ratio 20.90
P/E Ratio 22.60
Price Vs.BV 12.79
Latest Quarter
Year End 202509
Sales in Cr. 475.40
NP in Cr. 94.97
NP Var % 16.00
Trailing Twelve Months
Year End 202509
Sales 2,192.20
OPM 24.34
NP 421.55
NP Var% 4.45
EPS 160.35
PE 27.09